Nice | Gatroesophageal Reflux Disease (GORD) in Children

25th May 2015 by Louise Hudman

Nice | Gatroesophageal Reflux Disease (GORD) in Children

This is a new guideline from Nice on the management of GORD in infants and children.

The main differences from common practice is that they advice that PPI or H2 antagonists are only used if other specific symptoms are present too (see below). Most children with isolated GORD need no treatment.

GORD in infants

Reassure parents that gastroesophageal reflux is a normal process. GORD (where it causes symptoms) is present in 40% of infants. Most therefore need no treatment and just reassurance that it will get better with time.

Read more

No credit card details needed – it takes two minutes.

Join free trial


Already a member? Login to view this content.


"As a newly-qualified CCT and a GP moving to a new region post-CCT, I found LocumDeck and the NASGP to be very helpful. LocumDeck has been useful: Ali Lewis helped me to set myself up, get in touch with practices and book sessions, and also helped me chase payments. The NASGP itself, providing peer support and advice, has also been very good. I would certainly encourage my colleagues to join."

Dr Smita Sharma, GP, Hertfordshire

See the full list of features within our NASGP membership plans